Roth Capital Starts Spark Therapeutics (ONCE) at Buy
Tweet
Share
E-mailGet Alerts ONCE Hot Sheet
Price: $110.05 --0%
Rating Summary:
5 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 15 | New: 6
Rating Summary:
5 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 15 | New: 6
Join SI Premium – FREE
Roth Capital initiated coverage on Spark Therapeutics (NASDAQ: ONCE) with a Buy rating and a price target of $71.00.
For an analyst ratings summary and ratings history on Spark Therapeutics click here. For more ratings news on Spark Therapeutics click here.
Shares of Spark Therapeutics closed at $46.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Starts Jasper Therapeutics (JSPR) at Overweight
- JPMorgan Resumes Take-Two Interactive (TTWO) at Overweight
- Piper Sandler Starts Mercury Systems (MRCY) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
